Raymond James & Associates Cor Medix Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Cor Medix Inc. stock. As of the latest transaction made, Raymond James & Associates holds 47,837 shares of CRMD stock, worth $513,291. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,837

Previous 49,832 4.0%

Holding current value

$513,291

Previous $215,000 79.53%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$3.64 - $8.23 $7,261 - $16,418	-1,995 Reduced 4.0%	47,837 $386,000
Q2 2024 Jul 19, 2024	BUY	$4.08 - $6.39 $16,340 - $25,591	4,005 Added 8.74%	49,832 $215,000
Q1 2024 Apr 22, 2024	BUY	$2.94 - $4.24 $8,820 - $12,720	3,000 Added 7.0%	45,827 $194,000
Q4 2023 Jan 16, 2024	BUY	$3.0 - $4.01 $17,400 - $23,258	5,800 Added 15.66%	42,827 $161,000
Q3 2023 Oct 24, 2023	BUY	$3.6 - $4.46 $720 - $892	200 Added 0.54%	37,027 $136,000
Q2 2023 Jul 25, 2023	BUY	$3.94 - $5.8 $7,880 - $11,600	2,000 Added 5.74%	36,827 $145,000
Q1 2023 Apr 14, 2023	BUY	$3.22 - $4.61 $3,864 - $5,532	1,200 Added 3.57%	34,827 $144,000
Q1 2022 May 11, 2022	SELL	$3.83 - $6.24 $9,954 - $16,217	-2,599 Reduced 7.17%	33,627 $184,000
Q4 2021 Feb 08, 2022	BUY	$4.47 - $5.56 $17,053 - $21,211	3,815 Added 11.77%	36,226 $165,000
Q3 2021 Nov 02, 2021	BUY	$4.46 - $7.11 $49,671 - $79,184	11,137 Added 52.35%	32,411 $151,000
Q2 2021 Aug 11, 2021	SELL	$6.05 - $10.09 $17,091 - $28,504	-2,825 Reduced 11.72%	21,274 $146,000
Q1 2021 May 14, 2021	BUY	$6.84 - $17.58 $12,989 - $33,384	1,899 Added 8.55%	24,099 $241,000
Q3 2020 Nov 04, 2020	BUY	$3.96 - $6.15 $47,864 - $74,335	12,087 Added 119.52%	22,200 $134,000
Q2 2020 Jul 28, 2020	SELL	$3.08 - $6.56 $1,047 - $2,230	-340 Reduced 3.25%	10,113 $64,000
Q1 2020 Apr 21, 2020	BUY	$2.35 - $7.08 $24,564 - $74,007	10,453 New	10,453 $38,000

Others Institutions Holding CRMD

# of Institutions

180

Shares Held

32.7M

Call Options Held

867K

Put Options Held

561K

View Full List

About CorMedix Inc.

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $442M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

More about CRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Cor Medix Inc. Transaction History